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Abstract 
Background:  Non-hip non-vertebral fractures (NHNV) constitute the majority of 
osteoporotic fractures but few studies have examined the association between these fractures, 
co-morbidity and mortality.  
 
Objective: To examine the relationship between individual non-hip non-vertebral fractures, 
co-morbidities and mortality. 
 
Methods: 
Prospective population-based cohort of 267,043 subjects (45 and Up Study, Australia) had 
baseline questionnaires linked to hospital administrative and all-cause mortality data from 
2006 - 2013.  Associations between fracture and mortality examined using multivariate, time 
dependent Cox models, adjusted for age, prior fracture, body mass index, smoking and co-
morbidities (cardiovascular disease, diabetes, stroke, thrombosis and cancer) and survival 
function curves. Population attributable fraction calculated for each level of risk exposure. 
 
Results:  
During 1,490,651 person-years, women and men experienced 7,571 and 4,571 fractures and 
7,064 deaths and 11,078 deaths, respectively. In addition to hip and vertebral fractures, 
pelvis, humerus, clavicle, rib, proximal tibia/fibula, elbow and distal forearm fractures in both 
sexes, and ankle fractures in men, were associated with increased multivariable adjusted 
mortality hazard ratios ranging from 1.3 to 3.4. Co-morbidity independently added to 
mortality such that a woman with a humeral fracture and one co-morbidity had a similarly 
reduced 5 year survival to that of a woman with a hip fracture and no co-morbidities. 
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Population mortality attributable to any fracture without co-morbidity was 9.2% in women 
and 5.3% in men. 
 
Conclusion:  
All proximal non-hip, non-vertebral fractures in women and men were associated with 
increased mortality risk. Co-existent co-morbidities independently further increased 
mortality. Population attributable risk for mortality for fracture was similar to cardiovascular 
disease and diabetes, highlighting their importance and potential benefit for early intervention 
and treatment. 
 
Keywords: Epidemiology, Aging, Practice/ Policy-related issues 
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Introduction 
Premature mortality post-fracture is well established for hip and vertebral fractures (1-3). 
There is increasing evidence that a range of other, non-hip non-vertebral (NHNV), 
osteoporotic fractures are also associated with increased mortality (4-6). However, published 
data are inconsistent, particularly for distal forearm fractures (7, 8), or lacking for many other 
fractures.  
 
This potential association is important because NHNV fractures account for over 50% of 
fractures. Compared to hip and vertebral fractures, they receive less attention (9), possibly 
due to clinicians’ perception they are not associated with adverse consequences, or to 
difficulties accessing accurate data as they often do not require hospital admission.  However, 
there is increasing evidence that NHNV fractures contribute significantly to the burden of 
subsequent fractures (10, 11) and increased premature mortality (5, 12, 13). 
 
Previous studies of NHNV fractures and mortality have a number of limitations (8, 12, 14-
17). In particular, apart from sites such as the humerus (17, 18) and distal forearm (8, 19), 
NHNV fractures are commonly grouped (20, 21), due to limited fracture numbers for specific 
sites. In addition, data on co-morbidities, and other potential confounders for mortality, are 
often lacking. 
 
To overcome some of these limitations, we used a large population cohort with baseline co-
morbidity data and linkage capabilities to examine the relationship of hip, vertebral and 
multiple NHNV fracture sites with mortality. The study aims were to examine: (1) the 
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relationship between mortality and individual NHNV fracture sites, and (2) the independent 
contribution of fracture and co-morbidity to mortality.  
 
Subjects and Methods 
The Sax Institute’s 45 and Up study is a prospective cohort study of over 260,000 residents of 
New South Wales (NSW), Australia. NSW’s population accounts for one-third of Australia’s 
population. The study, described previously (22), included subjects 45 and older who were 
invited to participate via random sampling of the Department of Human Services (formerly 
Medicare Australia) enrolment database, which provides near complete coverage of the 
Australian population. To allow for deaths and loss to follow-up, the study over-sampled by a 
factor of two, individuals 80+ years and individuals in rural areas. Recruitment occurred 
between 2005 and 2009. The response rate was 18% and the study cohort was healthier and 
better educated than the general NSW population (23). Participants completed a baseline 
questionnaire and consented to data linkage to a number of administrative health datasets. For 
this analysis participants were followed until 31 December 2013. To ensure a minimum 12-
month follow-up post-fracture, participants who fractured in the last follow-up year were 
excluded.  
 
Questionnaire Variables 
Demographic data (age, date of recruitment, sex), lifestyle (smoking status, body mass index 
(BMI)) and co-morbidities were obtained from the baseline questionnaire. Co-morbidities 
included cardiovascular disease, cerebrovascular disease, thrombotic disorders, diabetes, 
melanoma, breast cancer, prostate cancer, and all other cancers including non-melanoma skin 
cancer and prior fracture within the last five years. For co-morbidities, participants were 
asked whether “a doctor ever told you that you have” the condition (Yes/No). BMI was 
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derived from self-reported height and weight. Smoking status was classified as never, 
previous or current. Alcohol intake was classified in three categories as none; within the 
Australian National Health and Medical Research Council guideline recommendations (≤ 2 
standard drinks/day for women and ≤ 4 standard drinks/day for men, with 2 alcohol free days 
per week for both sexes); and exceeding guidelines. 
 
Linked databases 
1. NSW Ministry of Health: Emergency Department Data Collection (EDDC): The EDDC 
collates presentations to all NSW public hospitals Emergency Departments. All 
Emergency Department presentations for diagnoses of fractures were used. International 
Classification of Diseases (ICD-10) (24) and Systematized Nomenclature of Medicine-
Clinical Terms (SNOMED-CT) (25) codes were used to identify fractures.  
2. NSW Ministry of Health: Admitted Patient Data Collection (APDC): The APDC collates 
inpatient separations (discharges, transfers and deaths) from all NSW public, private, and 
repatriation hospitals and private day procedure centres. These data include demographic 
characteristics, diagnoses and length of stay for individual episodes of hospital care. 
Diagnoses are coded according to the Australian modification  
3. NSW Registry of Births, Deaths and Marriages (RBDM): All-cause mortality data were 
identified using death registrations.  
 
Baseline questionnaire data from the 45 and Up Study were linked to the EDDC data, APDC 
data, and RBDM data. Probabilistic record linkage was performed by the Centre for Health 
Record Linkage. The 45 and Up Study was approved by the University of NSW Human 
Research Ethics Committee. Ethics approval for the current study was obtained from the 
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NSW Population Health Services Research Ethics Committee. Informed consent was not 
required for the current study as only de-identified data was used. 
 
Fracture identification 
Fractures were identified through a combination of SNOMED-CT and ICD-10 diagnosis 
codes from the APDC and EDDC as outlined above, and also using the Australian 
Classification of Health Interventions (ACHI) (26) procedure codes to capture fractures 
presenting as a day procedure. All SNOMED-CT and ICD-10 diagnosis codes suggesting 
fractures resulting from high trauma and pathological fractures were excluded. In participants 
with 2 or more fractures during one admission, only the more axial fracture, deemed the most 
severe, was counted. 
 
Outcome measures 
The primary outcome was all-cause mortality following each fracture type adjusted for age, 
lifestyle factors and co-morbidities. 
 
Statistical analysis 
Participants who died were compared to those alive at the study end for women and men 
separately. Student’s t-test was used to compare baseline characteristics for continuous 
variables and Pearson’s 𝝌𝝌2 test for categorical variables. Fracture incidence and mortality 
were calculated as fractures and deaths per 1000 person-years of follow-up. Fracture 
incidence was calculated for age groups: 45-59, 60-74 and 75+. Individual covariates were 
examined for their relationship with mortality using Cox’s proportional hazard models. 
Significance and 95% confidence intervals were calculated assuming a Poisson distribution.  
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Mortality rates were age standardised to the 2001 Australian population as recommended by 
the Australian Bureau of Statistics. As overall mortality rate of the study cohort was lower 
than the general Australian population, particularly in the 85+ age cohort, standardised 
mortality ratios, comparing the cohort and NSW population, are not presented. Mortality 
differences were compared within the cohort between fracture and non-fracture participants 
in several analyses. 
 
Cox’s proportional hazards regression was used to examine the association between fracture 
type and mortality with adjustment for covariates. Fracture was included as a time-dependent 
variable. Survival time was measured from recruitment until death or censor date. The 
proportional hazards assumption was checked for each variable by examining the residual 
plots. Thus age- and sex-specific adjusted hazard ratios (HR) were derived. Body mass index 
were missing in 11000 women (8.5%) and 7650 men (6.3%). These participants were 
excluded from the final modelling. Sensitivity analysis with imputation using the median 
BMI did not change the analysis meaningfully. 
 
To examine the effect of co-morbidities on survival for different fracture types, estimated 
survival function curves with covariates were plotted using the baseline function in SAS. We 
chose humeral fracture as representative of a NHNV fracture to compare with the known 
increased mortality of hip fracture. Curves were plotted for women and men aged 60 or 80 
for none, one or two co-morbidities, in addition to fracture. 
 
To calculate population attributable fraction, the heuristic approach was taken (17) using 
combinations of six key risks (fracture during the study; baseline cardiovascular disease, 
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diabetes, stroke, cancer and thrombosis) resulting in 64 possible exposure levels. Participants 
who did not fracture, with no co-morbidities were the reference.  
 
Analyses were performed using SAS 9.3 (SAS Institute, Inc. Cary, NC, USA).  
Results 
The study included data from 141,342 women and 122,877 men.  Mean age (SD) was 61.8 
(11.1) years in women and 63.8 (11.1) years in men. Mean follow-up was 5.67 (1.07) years 
for women and 5.60 (1.21) years for men, yielding 802,081 and 688,570 person-years of 
follow-up in women and men, respectively. The median time from fracture to death or study 
end was 2.6 years. In general, participants who died were older (P<0.001), more likely to 
have fractured (P<0.001), have had a prior fracture (P<0.001), have more co-morbidities 
(P<0.001) and, in men, have higher smoking rates (P<0.001) than participants who did not 
die during the follow-up period (Table 1). 
 
Fracture incidence 
During follow-up, women had 7,571 and men had 4,571 incident fractures, yielding fracture 
incidence rates of 9.71/1000 person-years (95% CI: 9.50-9.94) in women and 7.09/1000 
person-years (95% CI: 6.89-7.30) in men. Pattern of fractures were similar between women 
and men (Figure 1). NHNV accounted for over 70% of fractures in both women and men. 
There was an exponential increase in hip fractures, particularly after 75 years, and increased 
incidence of vertebral, pelvic, rib and humeral fractures with increasing age. Distal forearm 
fractures increased with age in women but not in men. By contrast, NHNV fracture at other 
sites, e.g. elbow and proximal tibia/fibula, remained relatively stable with increasing age. 
Women had more distal site (distal forearm and ankle) fractures than men (P<0.001).  
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Mortality  
Mortality rates were lower in the cohort than in the general Australian population (age 
adjusted rates: 17.3 vs 25.1 /1000 in women and 21.5 vs 27.7/1000 person-years in men. For 
the non-fracture study cohort, there were 5,981 deaths in 133,771 women and 10,068 deaths 
in 118,306 men yielding age-standardised mortality rates of 16.9/1000 person-years (95% CI: 
16.3-17.3) in women and 21.9/1000 person-years (95% CI: 20.5-23.2) in men. Among 
participants who had fractured, there were 1,083 and 1092 deaths in women and men, 
respectively with higher age-standardised mortality rates of 21.9/1000 person-years (95% CI: 
20.5-23.2) in women and 31.4/1000 person-years (95% CI: 29.4-33.4) in men.  
 
Specific co-morbidities associated with increased mortality included cardiovascular disease, 
diabetes, stroke, and thrombotic disorders with age-adjusted mortality HRs ranging from 1.2-
1.9 (Supplementary Table S1). Cancers other than breast or prostate were associated with the 
highest mortality risk (HR: 2.1-2.2). Low and high BMI and prior and current smoking were 
associated with increased mortality (HR: 1.4-2.7). Skin cancers other than melanoma were 
associated with a lower age-adjusted mortality risk. Alcohol intake in the cohort was low 
with 88% of women and 87% of men drinking within the recommended Australian alcohol 
guidelines or not drinking at all (non-drinkers: 41% and 23% in women and men, 
respectively). There was no clinically significant association between alcohol intake and 
mortality for either women or men. 
 
Fracture and mortality risk 
Increased mortality was observed for many different fracture sites in both women and men. 
This remained significant after multivariable adjustment (Figure 2, Supplementary Table S2). 
In general, mortality risk post fracture was greater in men than women (P<0.001). As 
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expected, the mortality risk post fracture was highest for the hip (women: 2.76 (95% CI: 2.46, 
3.09) and men: 3.40 (95% CI: 3.05, 3.78). Fractures of the vertebrae and pelvis were 
associated with increased mortality of similar magnitude. Interestingly, rib, humeral, elbow, 
proximal tibia/fibula and clavicular fractures all had similar associations with mortality risk 
with HRs between 2.00 and 2.50. Amongst distal fracture sites, distal forearm fractures were 
associated with increased mortality risk in both women and men. Ankle fractures, however, 
were only associated with an increased mortality risk in men. Mortality risk was not 
increased following fracture of the hands, feet, fingers and toes and did not differ from the 
non-fracture population. 
 
The estimated survival function curves highlight the relationship between fracture event, 
number of co-morbidities and survival (Figures 3a & 3b for women and men aged 60 and 80, 
respectively). For these analyses, co-morbidities selected were those most common in the 
cohort, namely cardiovascular disease and diabetes. These survival curves demonstrate 
fracture as a risk factor for mortality, and the additional independent contribution of co-
morbidities. Indeed a woman with a humerus fracture and one co-morbidity had the same 
estimated 5-year survival as a woman with a hip fracture and no co-morbidities. A man with 
a humeral fracture and one co-morbidity had a somewhat better survival than a man with a 
hip fracture and no co-morbidities but having 2 co-morbidities together with a humeral 
fracture resulted in a greater 5 year mortality than a hip fracture alone.  
 
Population attributable fraction  
The proportion of deaths in the population that could be attributed to fracture in individuals 
without co-morbidity was 9.2% in women and 5.3% in men. In women, the PAF was less 
than cancer but of a similar magnitude to cardiovascular disease and diabetes. Fracture 
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incidence was lower and cardiovascular disease higher in men than women; as a result the 
PAF of any fracture in men was less than cardiovascular disease but similar to diabetes and 
cancer. However, the contribution of fracture with or without any single co-morbidity 
resulted in a PAF for mortality that was similar to cancer in women and cardiovascular 
disease in men (Tables 2a & 2b).  
 
Discussion 
In this large population-based cohort study of subjects aged 45 and older, a large range of 
NHNV fractures, in addition to hip and vertebral fractures, were associated with increased 
mortality risk, after adjusting for age, prior fracture, smoking, BMI, cancer and other major 
co-morbidities. Virtually all NHNV fractures, including ribs, pelvis, femur, elbow, proximal 
tibia/fibula, distal forearm in both sexes, as well as ankle in men, were associated with 
increased mortality post fracture with hazard ratios ranging from 1.3 to 3.4.  Notably the 
mortality reported represents an early post fracture mortality with median time of 2.6 years 
from fracture to death or study end. Peripheral fractures of hands and feet were not associated 
with increased mortality. Moreover, this study demonstrated that co-morbidity contributed to 
mortality independently and additively from the fracture itself. The proportion of deaths that 
could be attributable to subjects with fracture alone or with fracture and one co-morbidity 
was of a similar magnitude to other major illnesses including cancer and heart disease, 
highlighting the magnitude of the problem. 
 
We found that hip and vertebral fractures were associated with 3.0-fold and 2.7-fold increase 
in mortality, respectively, similar to previous reports (3). In relation to NHNV post-fracture 
mortality, humeral fractures have been the most frequently studied, with consistent findings 
of increased mortality (2, 15, 17, 18). Our study supports these findings, demonstrating 
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humeral fractures were associated with a two-fold increase in mortality in women (HR: 2.0) 
and men (HR: 1.95) after multivariable adjustment. Prior studies which have demonstrated 
increased mortality have not always discriminated by sex (2) and none has adjusted for co-
morbidities (2, 15, 17, 18). Adjustment for co-morbidities in the current study had minimal 
effect on the fracture-mortality association itself but added an additional independent 
contribution to mortality.  
 
The relationship between distal forearm fractures and mortality is controversial with 
conflicting data. Studies have variously reported increased (8, 27), similar (2, 7, 20, 28) or 
decreased mortality (16, 19). We found significant mortality increases of 30% and 50% (HR 
1.30 and 1.50) in women and men, respectively and of a similar magnitude to the large 
Norwegian and Korean studies (8, 27). Previously published studies that did not find an 
association between mortality and distal forearm fractures may have been hindered by low 
fracture numbers (often below 200). Studies reporting increased mortality post distal forearm 
fractures generally had larger fracture numbers (27).  Bliuc et al (5) found a group of minor 
fractures, including distal forearm, were associated with increased mortality but only in 
subjects >75 years, with insufficient forearm fractures for separate analysis.  In a Medicaid 
US dataset where decreased mortality post distal forearm fractures was demonstrated (19), 
the authors postulated increased contact with the healthcare system as the cause. Unlike the 
USA, Australia has universal healthcare at all ages, perhaps explaining differences in 
findings between the USA and the current study.  
 
Few studies have examined mortality after rib fractures. Of these, only three examined rib 
fractures as a distinct group.  The Study of Osteoporotic Fractures reported a three-fold 
increased mortality following rib fractures in women (29). Of the remaining two studies, one 
 14 
found no difference in mortality risk but with only 16 and 11 rib fractures in men and 
women, respectively (25). In the other study (21) increased mortality risk post rib fractures 
was observed for women but not men. By contrast, in the current study, rib fractures were 
associated with an increased mortality risk of similar magnitude (two-fold) to vertebral 
fractures in both women and men.  
 
There is particularly limited evidence about other NHNV fracture sites. Previous studies 
generally did not find any association between mortality and other NHNV fractures but were 
limited by small numbers, leading to grouping of fractures and inability to adjust for co-
morbidities. Piirtola et al. did not find any association between “other miscellaneous” 
fractures (fractures other than hip, vertebra, ribs, proximal humerus and ankle) and mortality, 
but there were only 47 fractures over 12 years (12). Melton et al. reported “other arm” 
fractures (excluding proximal humerus and distal forearm) being associated with increased 
one-year mortality (13).  In the same study, the “other leg group” of fractures (all lower limb 
fractures other than hip, feet and toes), did not show increased mortality. We found two- to 
three-fold increased mortality following proximal tibia/fibula, elbow and distal femur 
fractures in both sexes. 
 
The specific causes of excess mortality following fracture are poorly understood. The 
duration of increased mortality attributable to fractures is also questionable, so pre-fracture 
co-morbidities have been hypothesised to contribute significantly to excess mortality with the 
fracture being a signal of underlying frailty. Several studies have examined the role of co-
morbidities, mainly following hip fracture (30-32). A large Danish hip fracture study did not 
demonstrate any association between mortality and pre-fracture co-morbidities (31). The 
major identified causes of mortality were post fracture complications. In the Fracture 
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Intervention Trial, adjustment for co-morbidities also did not affect mortality hazard ratios 
(28). Similarly, adjustment for co-morbidities in our study had minimal effect on the fracture-
specific hazard ratios although the presence of co-morbidities contributed additively and 
independently to mortality. Apart from the post fracture mortality, it has been demonstrated 
that low bone density (33), sarcopenia (34, 35), low body weight (21) and weight loss are 
independent predictors of both fracture and mortality and thus may play a role in any post 
fracture associated mortality. However, these variables are generally not available in large 
registry studies. 
 
One criticism of studies in this area is that control groups are often healthier with fewer co-
morbidities. The current study addressed this using both estimated survival curves and the 
heuristic approach to calculating population attributable fraction. The estimated survival 
curves demonstrate visually the difference in mortality risks between an individual with none, 
one or two co-morbidities following a fracture. In an individual with co-morbidities, fracture 
and co-morbidity were each independent risk factors for mortality, while the combination of 
both increased mortality risk. Indeed, a woman with a humeral fracture and one co-morbidity 
had a similarly reduced 5 year survival to that of a woman with a hip fracture and no co-
morbidities. Moreover, a fracture with either no or one co-morbidity, accounted for 19% of 
the deaths in women and 11% in men, which was similar to that for any other individual co-
comorbidity including both cancer and cardiovascular disease. Both approaches support 
fracture as an independent risk factor for mortality and the latter analysis demonstrates the 
significant contribution of fracture to overall population mortality. 
 
The strengths of the current study include the large sample size of women and men giving 
statistical power to study individual fracture sites. Unlike previous studies, this dataset 
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captures both community and inpatient data, allowing adjustment for lifestyle factors and 
medical co-morbidities. Furthermore, the study is the first to estimate population attributable 
fraction for each level of exposure and delineate the independent and additive effects of co-
morbidity to fracture-associated mortality.  
 
The limitations of the study include potential underestimation of mortality risk associated 
with fracture, as 45 and Up Study cohort mortality rates were significantly lower than the 
general NSW population. However, as increased mortality risk was still observed in this 
healthy group with fracture, it is likely that this risk would still be evident, and possibly 
higher, in the general population with a greater number of co-morbidities. Fractures were 
identified from administrative hospital data so it is possible that not all high trauma fractures 
were excluded or that only more severe distal fractures were included, potentially 
overestimating mortality risk in this group.  Moreover, the specifics of the fracture event 
itself was not able to be determined given the nature of the study. While validity of deaths 
and fracture data is high, validity of self-reported co-morbidities has not been well studied. 
However, administrative datasets are likely to under report co-morbid conditions compared 
with self-report (36). Medication use was not available in the current study so any effect of 
medication on survival could not be evaluated. 
 
Conclusion 
In this large cohort of healthy community-dwelling people, a wide range of non-hip non-
vertebral fractures were associated with increased mortality after multivariable adjustment. 
Importantly these NHNV fractures accounted for approximately 75% of fractures in this 
study. Compared to the non-fracture group, women and men with any fracture had a 19% and 
25% higher mortality rate, respectively. The population attributable fraction of mortality for 
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any fracture was 9.2% in women and 5.3% in men, similar in magnitude to other well 
described causes of mortality including cardiovascular disease, diabetes and cancer. 
Moreover, using estimated survival curves, this study demonstrated for the first time that 
individuals with co-morbidities had worse survival after a fracture than those who fractured 
but were co-morbidity free. This study highlights the potential benefit of early intervention 
after fracture to reduce risk of further fractures and possibly decrease mortality. 
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Table 1: Participant characteristics by sex and mortality outcome 
 Women (N = 141,342) Men (N = 122,877) 
Variable Alive 
(n = 134,278) 
Died 
(n = 7,064) 
Alive 
(n = 111,799) 
Died 
(n=11,078) 
Age, mean (SD), 
yrs 
61.0 (10.5) 76.7 (11.7)* 62.5 (10.4) 76.2 (10.2)* 
BMI, mean 
(SD), kg/m2 
26.7 (5.3)* 25.8 (5.7) 27.3 (4.2)* 26.2 (4.7) 
Fracture (%) 6,488 (4.8) 1,083 (15.3)* 3,561 (3.2) 1,010 (9.1)* 
Prior fracture 
within last 5 
yrs (%) 
16,071 (12.0) 1,509 (21.4)* 9,129 (8.2) 1,134 (10.2)* 
Ever smoked 
(%) 
47,178 (35.3) 2,506 (35.6) 55,834 (50.1) 6,920 (62.8)* 
 
Diseases 
Cardiovascular 
disease (%) 
9,775 (7.3) 1,693 (24.0)* 16,279(14.6)  3,603 (32.5)* 
Hypertension 
(%) 
44,004 (32.8) 3,230 (45.7)* 41,611 (37.2)  5,002 (45.2)* 
Diabetes (%) 9,154 (6.8) 1,073 (15.2)* 11,267 (10.1) 2,167 (19.6)* 
Stroke (%) 2,964 (2.2) 718 (10.2)* 3,421 (3.1) 1,187 (10.7)* 
Thrombosis (%) 7,058 (5.3) 711 (10.1)* 3,606 (3.2)  757 (6.8)* 
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Cancer (%) 14,075 (10.5) 1,829 (25.9)* 11,052 (9.9) 3,158 (28.5)* 
*P<0.001 for died vs alive  
Table 2a: Population attributable fraction (Women) 
 
Population Number Deaths Person-
years 
Mortality 
rate (/1000 
Person-
years) 
PAF (%) 
No fracture/co-
morbidity 
97,672 2,488 560,591 4.4  
Fracture only 4,684 455 26,837 17.0 9.2 
Cardiovascular 6,118 616 33,700 18.3 13.3 
Diabetes 6,016 368 33,745 10.9 6.1 
Cancer 10,965 922 60,678 15.2 18.5 
Stroke 1,434 188 7,795 24.1 4.4 
Thrombosis 4,272 176 24,364 7.2 1.9 
Fracture & 1 co-
morbidity 
2,074 394 11,333 34.8 10.0 
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Table 2b: Population attributable fraction (Men) 
 
Population Number Deaths Person-
years 
Mortality 
rate (/1000 
Person-years) 
PAF (%) 
No fracture/co-
morbidity 
81,300 4,252 463,458 9.2  
Fracture only 2,746 411 15,517 26.5 5.3 
Cardiovascular 12,201 1,659 66,776 24.8 21.3 
Diabetes 7,914 839 41,920 19.1 8.7 
Cancer 4,391 698 23,576 29.6 10.0 
Stroke 1,769 336 9,505 35.3 5.2 
Thrombosis 2,059 212 11,547 18.4 2.1 
Fracture & 1 
co-morbidity 
1,237 355 6,596 53.8 6.2 
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